Opsens Inc. (CVE:OPS – Get Rating) Senior Officer Robin Villeneuve sold 50,000 shares of the business’s stock in a transaction dated Thursday, May 26th. The shares were sold at an average price of C$2.11, for a total value of C$105,500.00. Following the completion of the sale, the insider now directly owns 35,000 shares of the company’s stock, valued at C$73,850.

Robin Villeneuve also recently made the following trade(s):

• On Thursday, May 19th, Robin Villeneuve sold 50,000 shares of Opsens stock. The shares were sold at an average price of C$1.79, for a total value of C$89,630.00.
• On Wednesday, April 20th, Robin Villeneuve sold 40,000 shares of Opsens stock. The shares were sold at an average price of C$2.36, for a total value of C$94,308.00.

CVE OPS traded down C$0.01 on Monday, hitting C$1.39. 24,700 shares of the company’s stock were exchanged, compared to its average volume of 42,144. The firm’s 50-day moving average price is C$1.39 and its two-hundred day moving average price is C$1.39. Opsens Inc. has a fifty-two week low of C$1.11 and a fifty-two week high of C$1.83.

Separately, Raymond James set a C$6.00 price target on Opsens and gave the company a “strong-buy” rating in a research report on Wednesday, April 27th.

About Opsens (Get Rating)

Opsens Inc provides fiber optic sensing technology. The Company operates through two segments: Medical and Industrial. In Medical segment, the Company focuses on the measure of Fractional Flow Reserve (FFR) in interventional cardiology. In Industrial segment, it develops, manufactures and installs fiber optic sensing solutions for critical applications, such as the monitoring of oil wells and other industrial applications.

Featured Stories

Receive News & Ratings for Opsens Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Opsens and related companies with MarketBeat.com’s FREE daily email newsletter.